XVII International Poxvirus, Asfivirus and Indorviurs Symposium
XVII International Poxvirus, Asfivirus and Indorviurs Symposium
批准号:
8006015
负责人:
Bertram L. Jacobs
金额:
$1.5万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-02 至 2011-05-31
关键词:
African Swine Fever-Like VirusesAmphibiaAnimal DiseasesAnimalsApplications GrantsAreaBiologyCell CommunicationCommunitiesEastern EuropeEducational workshopFishesFoodGene ExpressionGenomeGenomicsGovernmentHIV vaccineHealth FoodHumanInternationalIridovirusLearningMedicalMolecular BiologyMonkeypoxNational Institute of Allergy and Infectious DiseaseOralOrganismParticipantPathogenesisPostdoctoral FellowPoxviridaePoxviridae InfectionsProcessProphylactic treatmentProteomicsPublic HealthRegimenResearchResearch PersonnelResortScanningScienceScientistSignal TransductionSmallpoxSourceStructureTalentsTextTimeTranslatingUnited States National Institutes of HealthViralViral VectorVirionVirusWorkabstractingbasecareer developmentfightingfood securitygraduate studentimmunoregulationimprovedinterestmeetingsmortalitypathogenpostersprogramsresponsesuccesssymposiumtreatment strategyvaccine developmentvector vaccineviral DNA
中文摘要
描述(由申请人提供):
摘要
项目:1R13AI091299-01标题:第十七届国际痘病毒、黄斑病毒和虹膜病毒研讨会登录号:3255457
=
注意:此摘要摘自应用程序,未经SRA校对。如果应用程序扫描过程有问题,提取的文本可能不正确或不完整。
=
这份R13赠款提案已提交给NIAID,以支持将于2010年6月5-10日在亚利桑那州塞多纳的Poco Diablo度假村举行的XVIII国际痘病毒、AsfiVirus和IridoVirus研讨会。对于越来越多致力于研究痘和痘相关病毒的研究人员以及寻求更多了解这些病毒对基础和医学科学影响的科学家来说,这是一次重要的会议。2010年大会延续了每两年举行一次关于痘和痘相关病毒的研讨会式会议的传统。2010年会议预计将吸引约225人参加。科学计划将包括8个演讲环节,演讲者从以下主题领域提交的摘要中摘录:(1)病毒进入,(2)病毒转录和基因表达,(3)病毒DNA生物学和基因组结构(包括基因组学和蛋白质组学),(4)病毒粒子组装和出口,(5)病毒宿主细胞相互作用和信号传递,(6)免疫调节和发病机制,(7)病毒载体和疫苗,以及(8)预防和治疗。科学计划委员会将从提交的摘要中挑选发言者,并将担任这些会议的讨论负责人。该计划还将包括两个海报会议。为了鼓励初级科学家的职业发展,来自研究生和博士后队伍的摘要将优先提交。美国政府已通过美国国立卫生研究院动员力量,对天花和猴痘引起的公共卫生关切做出有效回应,并需要迅速将天花病毒分子生物学的最新进展转化为治疗和预防天花病毒感染的新的、安全和有效的策略。此外,东欧最近出现了一种虹彩病毒,人们认识到虹彩病毒是世界范围内鱼类和两栖动物死亡的主要因素,这使我们有机会将对痘和痘相关病毒感兴趣的病毒学家小组聚集在一起,讨论我们在应对这些重要的人类和动物病原体方面的进展。最后,随着最近一种基于痘病毒的艾滋病毒疫苗方案的部分成功,人们对改进痘病毒作为疫苗载体的兴趣重新燃起。第十八届国际痘病毒、AsfiVirus和虹彩病毒专题讨论会的时间安排非常理想,旨在提供一个讨论场所,讨论如何将对这些重要病毒基本生物学的新理解转化为能够改善人类健康和食品安全的方案,突出显示研究界响应新举措取得的进展,并继续吸引新的人才进入该领域。痘病毒引起人类天花和人类猴痘,与痘相关的病毒(阿斯菲亚病毒和虹膜病毒)感染作为人类食物来源的重要生物。痘病毒也是开发抗击人类和动物疾病的疫苗载体的前沿。因此,第十八届国际痘病毒、AsfiVirus和虹彩病毒专题讨论会非常适合为讨论如何将对这些重要病毒的基本生物学的新理解转化为可改善人类健康和粮食安全的方案提供一个场所。
英文摘要
DESCRIPTION (provided by applicant):
Abstract
PI: JACOBS, BERTRAM L. Project: 1R13AI091299-01 Title: XVII International Poxvirus, Asfivirus and Iridovirus Symposium Accession Number: 3255457
==================
NOTICE: THIS ABSTRACT WAS EXTRACTED FROM APPLICATION AND HAS NOT BEEN PROOFED BY AN SRA.WHEN THERE ARE PROBLEMS WITH THE APPLICATION SCANNING PROCESS, THE EXTRACTED TEXT MAY BE INCORRECT OR INCOMPLETE.
==================
This R13 grant proposal is submitted to NIAID for support of the XVIII International Poxvirus, Asfivirus and Iridovirus Symposium, to be held from June 5-10, 2010 at the Poco Diablo Resort in Sedona, AZ. This is the premier meeting for the growing community of researchers working on pox and pox-related viruses and for scientists seeking to learn more about the impact of these viruses on basic and medical science. The 2010 conference continues a tradition of workshop-style meetings on pox and pox-related viruses held every two years. The 2010 conference is expected to attract approximately 225 participants. The Scientific Program will consist of 8 sessions of oral presentations by speakers drawn from submitted abstracts in the following subject areas: (1) Virus entry, (2) Viral transcription and gene expression, (3) Viral DNA biology and genome structure (including genomics and proteomics), (4) Virion assembly and egress, (5) Virus host cell-interaction and signaling, (6) Immunomodulation and pathogenesis, (7) Viral vectors and vaccines, and (8) Prophylaxis and therapy. The Scientific Program Committee will select speakers from submitted abstracts and will serve as Discussion leaders for these sessions. The Program will also include two poster sessions. To encourage career development of junior scientists, abstracts from the ranks of graduate students and post-docs will be given priority for presentation. The US government, through NIH, has mobilized efforts to develop an effective response to the public health concerns regarding smallpox and monkeypox and the need to rapidly translate the recent advances in poxvirus molecular biology into new, safe and effective strategies for treatment and prophylaxis of poxvirus infections. In addition, the recent emergence of an asfivirus in Eastern Europe and the recognition of iridoviruses as central players in fish and amphibian mortalities world-wide, make this a unique opportunity to bring together the group of virologists interested in the pox and pox-related viruses to discuss our progress in dealing with these important human and animal pathogens. Finally, with the recent partial success of a poxvirus-based HIV vaccine regimen, there is renewed interest in improving poxviruses as vaccine vectors. The timing of the XVIII International Poxvirus, Asfivirus and Iridovirus Symposium is ideally tailored to providing a venue for discussions of how new understanding of the basic biology of these important viruses can be translated into regimens that can improve human health and food security, highlighting the advances achieved by the research community in response to new initiatives and to continue to draw new talent into the field. Poxviruses cause human smallpox and human monkeypox, and the pox-related viruses (asfiviruses and iridoviruses) infect organisms important as human food sources. Poxviruses are also in the forefront for development of vaccine vectors to fight human and animal diseases. Thus, the XVIII International Poxvirus, Asfivirus and Iridovirus Symposium is ideally suited to providing a venue for discussions of how new understanding of the basic biology of these important viruses can be translated into regimens that can improve human health and food security.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Monkeypox virus, Interferon, and Necroptosis
-
批准号:10678914
-
项目类别:
-
资助金额:$41.83万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
Monkeypox virus, Interferon, and Necroptosis
-
批准号:10241530
-
项目类别:
-
资助金额:$47.68万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
DsRNA Characterization in Monkeypox-infected Cells
-
批准号:8372121
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
Monkeypox virus, Interferon, and Necroptosis
-
批准号:10455608
-
项目类别:
-
资助金额:$54.12万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
DsRNA Characterization in Monkeypox-infected Cells
-
批准号:8653927
-
项目类别:
-
资助金额:$38.3万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
Monkeypox virus, Interferon, and Necroptosis
-
批准号:10052748
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
DsRNA Characterization in Monkeypox-infected Cells
-
批准号:8473158
-
项目类别:
-
资助金额:$36.0万
-
财政年份:2012
-
负责人:Bertram L. Jacobs
-
依托单位:
Disabling Vaccinia IFNr: A New Smallpox Vaccine
-
批准号:7491011
-
项目类别:
-
资助金额:$78.44万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Disabling Vaccinia IFNr: A New Smallpox Vaccine
-
批准号:7091654
-
项目类别:
-
资助金额:$41.81万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Disabling Vaccinia IFNr: A New Smallpox Vaccine
-
批准号:7285053
-
项目类别:
-
资助金额:$10.84万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Development of a post-exposure vaccine for smallpox
-
批准号:6998645
-
项目类别:
-
资助金额:$109.74万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Disabling Vaccinia IFNr: A New Smallpox Vaccine
-
批准号:6988269
-
项目类别:
-
资助金额:$49.33万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Disabling Vaccinia IFNr: A New Smallpox Vaccine
-
批准号:7283015
-
项目类别:
-
资助金额:$77.77万
-
财政年份:2005
-
负责人:Bertram L. Jacobs
-
依托单位:
Development of a Safer Smallpox Vaccine
-
批准号:6802262
-
项目类别:
-
资助金额:$93.26万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Development of a Safer Smallpox Vaccine
-
批准号:7086393
-
项目类别:
-
资助金额:$128.55万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Role of the E3L gene in poxvirus pathogenesis
-
批准号:7159400
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Development of a Safer Smallpox Vaccine
-
批准号:7283126
-
项目类别:
-
资助金额:$112.4万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Role of the E3L gene in poxvirus pathogenesis
-
批准号:6840547
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Role of the E3L gene in poxvirus pathogenesis
-
批准号:7017107
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
Development of a Safer Smallpox Vaccine
-
批准号:6892399
-
项目类别:
-
资助金额:$165.88万
-
财政年份:2003
-
负责人:Bertram L. Jacobs
-
依托单位:
海外基金